Loading…
Based on limited metadata, the FDA issued a warning letter to Chemland Co., Ltd., a pharmaceutical manufacturer, on February 11, 2020. While the specific violations cannot be detailed without access to the full letter text, the warning indicates that the company's drug manufacturing or distribution practices did not meet FDA regulatory standards. The letter falls under FDA's drug product oversight, though the specific issuing office and violation details are not available in the metadata provided.